当 AI 开始为 AI 造“认知外骨骼”：不训模型，也能让小 AI 能力翻倍？AI4AI 正从这里开始

2026 年，AI 领域正在发生一个很容易被普通用户忽略、却可能相当深刻的变化。过去几年，行业讨论 AI 能力时，最常见的问题一直是：模型有多大？推理有多强？下一代模型又提升了多少？但到了今年，越来越多注意力开始从 “模型本身” 移向模型周围的整个系统。2 月，OpenAI 就开始以 Harness Engineering 为题讨论如何通过环境、规则、验证机制和工程约束让 Agent 更可靠； 7 ...
Tech Times on MSN

Ray Summit 2026: RL post-training forces open-source AI infrastructure to converge

Ray Summit 2026 opens today in San Francisco as the first-ever vLLM Conference runs concurrently under the same roof. The ...
pharmaphorum

Company Profile: Recursion

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...
pharmaphorum

Change at the top of Recursion as co-founder leaves CEO role

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...
HackerNoon

The Six-Day Mystery That Rewrote AI's Price List

AI Coding Tip 030 - Turn Repeatable Skill Steps Into Tested Scripts Instead of Prompts 20 August —OpenCode announces the ...
Yahoo Finance

Recursion Pharmaceuticals, Inc. (RXRX)

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
腾讯网

当AI开始为AI造“认知外骨骼”：不训模型，也能让小AI能力翻倍？

2026 年，AI 领域正在发生一个很容易被普通用户忽略、却可能相当深刻的变化。过去几年，行业讨论 AI 能力时，最常见的问题一直是：模型有多大？推理有多强？下一代模型又提升了多少？但到了今年，越来越多注意力开始从 “模型本身” ...
Barron's

Recursion Pharmaceuticals Inc.

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...